CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 84 enrolled
Drug / intervention
Code STD +2 moredrug
Likely dose
Code STD 2 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01238640
NCT01238640N/ACompleted
CompareCT.gov

Bioequivalence Between Two New Oral Nicotine Replacement Therapy Products and Nicorette® Microtab. A Study in Healthy Smokers

McNeil AB·interventional·Posted Nov 10, 2010·Updated Jul 13, 2012

In Brief

A clinical study evaluating Code STD, Code STE, and 1 other intervention for Tobacco Dependence. Completed, enrolled 84 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the bioequivalence between two new oral nicotine replacement therapy products and Nicorette® microtab.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Dependence
CountriesSweden
Collaborators--

Timeline

N/ACompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 10, 2010
Enrollment StartAug 1, 2008
Primary CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.6 years ago

Interventions

Code STDdrug

2 mg Single-dose of experimental nicotine product coded "STD"

Code STEdrug

2 mg Single-dose of experimental nicotine product coded "STE"

Nicorette Microtabdrug

A comparative 2 mg Single-dose of marketed tablet